Inherited heart diseases pose unique challenges due to their genetic origins, often affecting multiple family members across generations. Conditions such as Marfan syndrome, long QT syndrome, and dilated cardiomyopathy are caused by mutations in specific genes, leading to structural or electrical abnormalities in the heart. As these diseases may remain asymptomatic for years, genetic testing plays a crucial role in early diagnosis, allowing for proactive management to prevent complications like heart failure or arrhythmias. Treatment approaches are highly individualized, ranging from medication and lifestyle modifications to advanced interventions such as implantable devices. Research into gene therapy and other cutting-edge treatments continues to offer hope for those with genetic and inherited heart diseases, promising improved quality of life and better long-term outcomes.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation